Vertex Pharmaceuticals

Undaunted Vertex closes in on FDA nod for non-opioid pain drug

While other companies gave up on trying to develop a non-opioid pain relief medicine by targeting sodium channel inhibition, Vertex stayed the course.

Kevin Dunleavy Oct 28, 2024 5:00am

Rectify drug repairs bile composition in mice with liver disease

Oct 22, 2024 7:00am

Vertex pain data: Combo results, Vicodin miss and stellar safety

Oct 21, 2024 9:55am

gene edits scientists gene editing CRISPR

Editas cashes in on Vertex Cas9 licensing agreement for $57M

Oct 4, 2024 5:06am

Vertex, beaten by AATD again, drops 2 assets on discard pile

Aug 2, 2024 5:39am

Vertex mines for more gene editing riches with $15M Orum deal

Jul 16, 2024 7:00am